Active	Status	Sponsor type	Region	Phase	Filter
1 Active 0 Inactive 1 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
zifibancimig (RG6120) / Roche
BURGUNDY, NCT04567303: Study of Zifibancimig in Participants With Neovascular Age-Related Macular Degeneration	Recruiting	1/2	251	US	Zifibancimig, RO7250284, Ranibizumab, Port Delivery Platform	Hoffmann-La Roche	Macular Degeneration	02/26	12/27